Browsing byAuthor문영철

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 31 to 60 of 186

Issue DateTitleAuthor(s)Type
2014Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea문영철Article
2012Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)문영철Article
2009Clinical features and survival outcomes in patients with multiple myeloma: Analysis of web-based data from the korean myeloma registry문영철Article
2013Clinical features and treatment outcome of primary systemic light-chain amyloidosis in Korea: Results of multicenter analysis문영철Article
2017CLINICAL IMPACT BY 24 MONTHS ACCORDING TO BCR/ABL1 TRANSCRIPT LEVEL AT 3 AND 6 MONTHS IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH RADOTINIB 300MG BID OR IMATINIB문영철Meeting Abstract
2021Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone문영철Article
2019Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis문영철Article
2015Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma문영철Article
2019Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System문영철Article
2016CLINICOPATHOLOGIC CHARACTERISTICS ASSOCIATED WITH NATURAL KILLER CELL ACTIVITY BY MEASUREMENT OF INTERFERON-GAMMA IN HEMATOLOGIC MALIGNANCIES성주명; 허정원; 문영철Meeting Abstract
2015CLINICOPATHOLOGIC CHARACTERISTICS OF UNCLASSIFIABLE MYELOPROLIFERATIVE NEOPLASMS문영철Meeting Abstract
2018Clinicopathological Characteristics of Hyperdiploidy with High-Risk Cytogenetics in Multiple Myeloma성주명; 허정원; 문영철Article
2013Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes성주명; 문영철Article
2017COMPARISON OF MOLECULAR KINETICS AFTER THE FIRST AND SECOND IMATINIB DISCONTINUATION: RESULTS FROM THE KID STUDY문영철Meeting Abstract
2011Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: Surgical resection followed by chemotherapy versus chemotherapy alone문영철Article
2010Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine문영철Article
2021Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia문영철Article
2021Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia이미애; 성주명; 허정원; 문영철; 박영미; 정혜선; 박설희; 김이준Article
2017Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy문영철Article
2021Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia문영철Article
2019Degranulated Eosinophils Contain More Fine Nerve Fibers in the Duodenal Mucosa of Patients With Functional Dyspepsia정혜경; 문영철; 박상희Article
2021Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and F-18-FDG PET/CT문영철Article
2007Early imatinib mesylate-induced hepatotoxicity in chronic myelogenous leukaemia이순남; 성주명; 조민선; 이경은; 문영철; 남은미Article
2017EARLY PREDICTION OF THE MOLECULAR RESPONSE TO BCR-ABL1 TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA문영철Meeting Abstract
2013Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation문영철Article
2014Effect of anemia correction on left ventricular structure and filling pressure in anemic patients without overt heart disease신길자; 권기환; 문영철Article
2023Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study문영철Article
2018Efficacy and safety of a new 10% intravenous immunoglobulin product in patients with primary immune thrombocytopenia (ITP)문영철Article
2016Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study문영철Article
2015Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients: 12 Months Result of Phase 3 Clinical Trial문영철Meeting Abstract

BROWSE